Voya Investment Management LLC Apellis Pharmaceuticals, Inc. Transaction History

Voya Investment Management LLC

$86.1 Billion
Q1 2024

A detailed history of Voya Investment Management LLC transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Voya Investment Management LLC holds 494,692 shares of APLS stock, worth $19 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

494,692

Previous 256,533 92.84%

Holding current value

$19 Million

Previous $15.4 Million 89.35%

% of portfolio

0.03%

Previous 0.02%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$55.39 - $72.47 $13.2 Million - $17.3 Million	238,159 Added 92.84%	494,692 $29.1 Million
Q4 2023 Feb 14, 2024	BUY	$37.14 - $64.82 $6.48 Million - $11.3 Million	174,366 Added 212.21%	256,533 $15.4 Million
Q3 2023 Nov 14, 2023	SELL	$23.65 - $89.22 $3.29 Million - $12.4 Million	-139,247 Reduced 62.89%	82,167 $3.13 Million
Q2 2023 Aug 14, 2023	SELL	$76.68 - $93.31 $3.88 Million - $4.72 Million	-50,543 Reduced 18.58%	221,414 $20.2 Million
Q1 2023 May 15, 2023	BUY	$46.59 - $66.96 $5.31 Million - $7.63 Million	113,880 Added 72.04%	271,957 $17.9 Million

Q4 2022 Feb 14, 2023	SELL	$43.24 - $61.04 $313,619 - $442,723	-7,253 Reduced 4.39%	158,077 $8.17 Million
Q3 2022 Mar 03, 2023	BUY	$44.76 - $69.66 $324,644 - $505,243	7,253 Added 4.59%	165,330 $11.3 Million
Q3 2022 Nov 14, 2022	BUY	$44.76 - $69.66 $2 Million - $3.12 Million	44,758 Added 37.12%	165,330 $11.3 Million
Q2 2022 Aug 15, 2022	BUY	$35.07 - $59.21 $861,424 - $1.45 Million	24,563 Added 25.58%	120,572 $5.45 Million
Q1 2022 May 16, 2022	SELL	$35.46 - $54.12 $278,963 - $425,762	-7,867 Reduced 7.57%	96,009 $4.88 Million
Q4 2021 Feb 14, 2022	BUY	$30.74 - $49.16 $2.42 Million - $3.87 Million	78,732 Added 313.12%	103,876 $4.91 Million
Q3 2021 Nov 15, 2021	SELL	$31.4 - $69.84 $10,581 - $23,536	-337 Reduced 1.32%	25,144 $829,000
Q2 2021 Aug 16, 2021	SELL	$40.9 - $64.9 $44,090 - $69,962	-1,078 Reduced 4.06%	25,481 $1.61 Million
Q1 2021 May 17, 2021	BUY	$40.8 - $57.39 $7,384 - $10,387	181 Added 0.69%	26,559 $1.14 Million
Q4 2020 Feb 16, 2021	BUY	$30.79 - $57.2 $61,580 - $114,400	2,000 Added 8.2%	26,378 $1.51 Million
Q3 2020 Nov 16, 2020	BUY	$25.89 - $33.65 $91,158 - $118,481	3,521 Added 16.88%	24,378 $735,000
Q2 2020 Aug 14, 2020	SELL	$24.8 - $38.49 $182,949 - $283,940	-7,377 Reduced 26.13%	20,857 $681,000
Q1 2020 May 15, 2020	BUY	$17.91 - $44.33 $76,063 - $188,269	4,247 Added 17.71%	28,234 $756,000
Q4 2019 Feb 14, 2020	BUY	$22.1 - $30.8 $116,268 - $162,038	5,261 Added 28.09%	23,987 $734,000
Q2 2019 Aug 14, 2019	BUY	$18.0 - $25.34 $66,420 - $93,504	3,690 Added 24.54%	18,726 $475,000
Q1 2019 May 15, 2019	SELL	$12.81 - $19.82 $8,762 - $13,556	-684 Reduced 4.35%	15,036 $293,000
Q4 2018 Feb 14, 2019	BUY	$11.47 - $18.71 $18,592 - $30,328	1,621 Added 11.5%	15,720 $207,000
Q2 2018 Aug 14, 2018	BUY	$19.63 - $30.0 $276,763 - $422,970	14,099 New	14,099 $310,000

Others Institutions Holding APLS

# of Institutions

337

Shares Held

111M

Call Options Held

1.26M

Put Options Held

1.14M

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $4.21B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Voya Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Voya Investment Management LLC with notifications on news.

Account

Voya Investment Management LLC Apellis Pharmaceuticals, Inc. Transaction History